logo
BioCryst: Q2 Earnings Snapshot

BioCryst: Q2 Earnings Snapshot

By AP News
Published - Aug 05, 2024, 11:21 AM ET
Last Updated - Aug 05, 2024, 11:21 AM EDT

DURHAM, N.C. (AP) — DURHAM, N.C. (AP) — BioCryst Pharmaceuticals Inc. (BCRX) on Monday reported a loss of $12.7 million in its second quarter.

The Durham, North Carolina-based company said it had a loss of 6 cents per share.

The results topped Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for a loss of 19 cents per share.

The drugmaker posted revenue of $109.3 million in the period, which also beat Street forecasts. Five analysts surveyed by Zacks expected $98.3 million.

Our Offices
  • 10kInfo, Inc.
    13555 SE 36th St
    Bellevue, WA 98006
  • 10kInfo Data Solutions, Pvt Ltd.
    Claywork Create
    11 km, Arakere Bannerghatta Rd, Omkar Nagar, Arekere,
    Bengaluru, Karnataka 560076
4.2 12182024